Enveric Biosciences Announces Two Poster Presentations at the 6th Neuropsychiatric Drug Development Summit

Presentations highlight research involving Enveric’s EVM301 Series of non-hallucinogenic neuroplastogens and the company’s lead product candidate, EB-373

...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Australia ,Boston ,Massachusetts ,United States ,Enveric Biosciences ,Jillianm Hagel ,D Enveric Biosciences ,Peter Facchini ,Natali Ozber ,Joseph Tucker ,Charlie Cai ,Josephe Tucker ,Jessicab Lee ,Lisa Yu ,Kaveh Matinkhoo ,Stanley Opare ,Sheetala Raithatha ,Sarahg Cook ,Jaideep Bains ,Peterj Facchini ,Govinda Sharma ,Jaideeps Bains ,Neuropsychiatric Drug Development Summit ,Exchange Commission ,Chief Innovation Officer ,Limei Chang ,Glynnis Jensen ,David Press ,Jonathan Gallant ,New Chemical Entities ,Annual Report ,Quarterly Reports ,Markets ,